000 01549 a2200481 4500
005 20250517115332.0
264 0 _c20170717
008 201707s 0 0 eng d
022 _a1873-5835
024 7 _a10.1016/j.leukres.2016.08.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerman, Ellin
245 0 0 _aResistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS).
_h[electronic resource]
260 _bLeukemia research
_c10 2016
300 _a108-12 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
_xpharmacology
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMutagenesis, Insertional
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aRNA Splicing
_xgenetics
650 0 4 _aRetrospective Studies
650 0 4 _aSequence Analysis, DNA
650 0 4 _aTreatment Failure
650 0 4 _aYoung Adult
700 1 _aJhanwar, Suresh
700 1 _aHedvat, Cyrus
700 1 _aArcila, Maria E
700 1 _aWahab, Omar Abdel-
700 1 _aLevine, Ross
700 1 _aMaloy, Molly
700 1 _aMa, Wanlong
700 1 _aAlbitar, Maher
773 0 _tLeukemia research
_gvol. 49
_gp. 108-12
856 4 0 _uhttps://doi.org/10.1016/j.leukres.2016.08.006
_zAvailable from publisher's website
999 _c26444576
_d26444576